Showing 1–16 of 204 results
-
ACTEMRA (tocilizumab) injection, for intravenous or subcutaneous use Initial U.S. Approval: 2010
Read more -
ADAKVEO (crizanlizumab-tmca) injection, for intravenous use. Initial U.S. Approval: 2019
Read more -
AKEEGA (niraparib and abiraterone acetate) tablets
Read more -
ALIQOPA (copanlisib) for injection, for intravenous use. Initial U.S. Approval: 2017
Read more -
AMVUTTRA (vutrisiran) injection
Read more -
ANDEXXA (coagulation factor Xa (recombinant), inactivated-zhzo). Lyophilized powder for solution for intravenous injection. Initial U.S. Approval: 2018
Read more -
Atriance (nelarabine) for injection
Read more -
AUGTYRO (repotrectinib) capsules
Read more -
AVASTIN (bevacizumab) Solution for intravenous infusion. Initial U.S. Approval: 2004
Read more -
AVSOLA (infliximab-axxq) for injection, for intravenous use. Initial U.S. Approval: 2019
Read more -
AYVAKIT (avapritinib) tabletsAYVAKIT (avapritinib) tablets, for oral use. Initial U.S. Approval: 2020
Read more -
BALVERSA (erdafitinib) tablets
Read more -
Bevacizumab Injection. Initial U.S. Approval: 2004
Read more -
BIKTARVY (bictegravir, emtricitabine, and tenofovir alafenamide) tablets, for oral use. Initial U.S. Approval: 2018
Read more -
BIMZELX (bimekizumab-bkzx) injection
Read more -
BLENREP (belantamab mafodotin-blmf) for injection, for intravenous use. Initial U.S. Approval: 2020
Read more